Wto Trade Waiver
- All
- News
-
Minister Pitches Patent Waiver For Covid Treatment To Global South
Commerce and Industry Minister Piyush Goyal on Friday pitched for increasing efforts at the World Trade Organisation (WTO) for getting patent waivers for diagnostics and therapeutics used to deal with the Covid-19 pandemic.
-
India Said to Oppose Moratorium on Customs Duties on E-Commerce Trade at Next WTO Meeting
India is said to oppose the continuation of moratorium on customs duties on e-commerce trade at the next WTO's meeting in Geneva. Waiver on custom duties adversely impacting the developing countries, said an official.
-
India To Push For Patent Waiver For Covid Vaccines At World Trade Body
India will lead demands for an intellectual property rights waiver for COVID-19 vaccines and supplies at a World Trade Organization (WTO) meeting next week, two government officials said.
-
Will Review Text On India's Patent Waiver Move For Covid Vaccines: UK
The UK will look at any text submitted to the World Trade Organisation (WTO) seeking an intellectual property (IP) waiver to boost the supply and production of COVID-19 vaccines, the minister in charge of the UK's COVID-19 vaccine deployment said.
-
Global Trade Body Takes First Step In Patent Waiver Talks For Covid Jabs
After months of debate, World Trade Organization (WTO) members on Wednesday took a first, small step towards a deal aimed at boosting production of Covid vaccines and treatments through patent waivers or compulsory licensing deals.
-
World Bank Opposes Vaccine Intellectual Property Waiver As WTO Talks Resume
The World Bank has opposed waiving intellectual property rights for COVID-19 vaccines at the World Trade Organization.
-
EU, UK Raise Doubts About Covid Vaccine Patent Waiver
The EU, Britain and Japan continued to voice doubts at the WTO on Monday about a proposed intellectual property waiver on Covid-19 products such as vaccines, a Geneva trade official said.
-
US Support For Patents Waiver On Vaccines Significant Step: Envoy
The US is ramping up efforts in partnership with India and other countries to increase the availability of COVID-19 vaccines without waiting for the World Trade Organisation (WTO) to arrive at a consensus-based decision on a proposal for patents wai
-
Switzerland Looking At 'New Situation' As US Backs Covid Vaccines Patent Waiver
Switzerland on Friday said it is looking at the new situation arising out of the United States backing an initiative to temporarily waive patent rules for COVID-19 vaccines.
-
India Welcomes US Support To Covid Vaccines' Patent Protection Waiver
Welcoming the US support for global waiver on patent protection for COVID-19 vaccines, India on Thursday said it is hopeful that the waiver can be approved quickly at the World Trade Organisation (WTO) with a consensus-based approach.
-
US Backs Covid Vaccine Patent Waiver Plan Proposed By India, South Africa
US President Joe Biden's administration on Wednesday announced support for a global waiver on patent protections for Covid-19 vaccines, offering hope to poor nations that have struggled to access the life-saving doses.
-
Diplomats From India, South Africa Try To Gather Support In US On WTO Proposal
Diplomats from India and South Africa are working together to convince American lawmakers and policymakers on the need to support their proposal before the WTO to temporary waive some of the Trade-Related Aspects of Intellectual Property Rights (TRIP
-
US Non-Committal On India's Move For Waiver To Covid Vaccines At WTO
The US remained non-committal on the move by India and South Africa to get Trade-Related Aspects of Intellectual Property Rights waiver for Covid vaccine before the WTO so that the doses are accessible and affordable to low- and middle-income nation
-
Joe Biden Urged To Back India, South Africa Before WTO On Covid Vaccines
A group of American lawmakers has urged President Joe Biden to support the move by India and South Africa before the World Trade Organization for an emergency temporary waiver of some Trade-Related Aspects of Intellectual Property Rights (TRIPS) rules to enable greater production and supply of COVID-19 vaccines, treatments, and diagnostic tests.
-
Minister Pitches Patent Waiver For Covid Treatment To Global South
Commerce and Industry Minister Piyush Goyal on Friday pitched for increasing efforts at the World Trade Organisation (WTO) for getting patent waivers for diagnostics and therapeutics used to deal with the Covid-19 pandemic.
-
India Said to Oppose Moratorium on Customs Duties on E-Commerce Trade at Next WTO Meeting
India is said to oppose the continuation of moratorium on customs duties on e-commerce trade at the next WTO's meeting in Geneva. Waiver on custom duties adversely impacting the developing countries, said an official.
-
India To Push For Patent Waiver For Covid Vaccines At World Trade Body
India will lead demands for an intellectual property rights waiver for COVID-19 vaccines and supplies at a World Trade Organization (WTO) meeting next week, two government officials said.
-
Will Review Text On India's Patent Waiver Move For Covid Vaccines: UK
The UK will look at any text submitted to the World Trade Organisation (WTO) seeking an intellectual property (IP) waiver to boost the supply and production of COVID-19 vaccines, the minister in charge of the UK's COVID-19 vaccine deployment said.
-
Global Trade Body Takes First Step In Patent Waiver Talks For Covid Jabs
After months of debate, World Trade Organization (WTO) members on Wednesday took a first, small step towards a deal aimed at boosting production of Covid vaccines and treatments through patent waivers or compulsory licensing deals.
-
World Bank Opposes Vaccine Intellectual Property Waiver As WTO Talks Resume
The World Bank has opposed waiving intellectual property rights for COVID-19 vaccines at the World Trade Organization.
-
EU, UK Raise Doubts About Covid Vaccine Patent Waiver
The EU, Britain and Japan continued to voice doubts at the WTO on Monday about a proposed intellectual property waiver on Covid-19 products such as vaccines, a Geneva trade official said.
-
US Support For Patents Waiver On Vaccines Significant Step: Envoy
The US is ramping up efforts in partnership with India and other countries to increase the availability of COVID-19 vaccines without waiting for the World Trade Organisation (WTO) to arrive at a consensus-based decision on a proposal for patents wai
-
Switzerland Looking At 'New Situation' As US Backs Covid Vaccines Patent Waiver
Switzerland on Friday said it is looking at the new situation arising out of the United States backing an initiative to temporarily waive patent rules for COVID-19 vaccines.
-
India Welcomes US Support To Covid Vaccines' Patent Protection Waiver
Welcoming the US support for global waiver on patent protection for COVID-19 vaccines, India on Thursday said it is hopeful that the waiver can be approved quickly at the World Trade Organisation (WTO) with a consensus-based approach.
-
US Backs Covid Vaccine Patent Waiver Plan Proposed By India, South Africa
US President Joe Biden's administration on Wednesday announced support for a global waiver on patent protections for Covid-19 vaccines, offering hope to poor nations that have struggled to access the life-saving doses.
-
Diplomats From India, South Africa Try To Gather Support In US On WTO Proposal
Diplomats from India and South Africa are working together to convince American lawmakers and policymakers on the need to support their proposal before the WTO to temporary waive some of the Trade-Related Aspects of Intellectual Property Rights (TRIP
-
US Non-Committal On India's Move For Waiver To Covid Vaccines At WTO
The US remained non-committal on the move by India and South Africa to get Trade-Related Aspects of Intellectual Property Rights waiver for Covid vaccine before the WTO so that the doses are accessible and affordable to low- and middle-income nation
-
Joe Biden Urged To Back India, South Africa Before WTO On Covid Vaccines
A group of American lawmakers has urged President Joe Biden to support the move by India and South Africa before the World Trade Organization for an emergency temporary waiver of some Trade-Related Aspects of Intellectual Property Rights (TRIPS) rules to enable greater production and supply of COVID-19 vaccines, treatments, and diagnostic tests.
